Nami Surgical announced it raised $4 million in investment and grant funding to support its robotic-assisted surgery platform. Glasgow, Scotland-based Nami develops miniaturized ultrasonic medical devices for surgical applications. It also supports medical device companies in ultrasonic surgery. The company’s high-performance, miniaturized ultrasonic scalpel aims to overcome barriers in robotic-assisted surgery.
Related: Aisap’s AI ultrasound tool secures $13m in seed funding
According to a news release, ultrasonic scalpels — traditionally favored in laparoscopic procedures — often prove too large for effective use in robotics. That is, until Nami brings its technology to the space. The company believes its ultrasonic scalpels in robotic surgeries could set a new benchmark in surgical care.
St. Andrews, Scotland-based impact investment firm EOS Advisory led the seed round with $3.1 million. The Investment Fund for Scotland — managed by UK private equity firm Maven — led the round along with EOS. Separately, Nami received a grant from the UK’s national innovation agency, Innovate UK.
“Robot-assisted surgery has become increasingly popular in recent years and is now widely used in various surgical procedures including urology, gynecology, and colorectal,” said Nami Surgical CEO and co-founder Nico Fenu said. “We have pilot programs running with healthcare and medical device groups worldwide, including in the United States, and we now look forward to the commercialization phase with the support of our new investors.”
